| 美国的药品安全监管体制对我国的启示 |
| |
| 引用本文： | 郭莹,袁红梅.美国的药品安全监管体制对我国的启示[J].中国药物警戒,2013(10):607-608,613. |
| |
| 作者姓名： | 郭莹 袁红梅 |
| |
| 作者单位： | 沈阳药科大学工商管理学院,辽宁沈阳110016 |
| |
| 摘 要： | 目的研究美国的药品安全监管体制,并针对我国目前存在的主要问题,提出对完善我国药品安全监管体制的启示。方法主要采用文献研究法。结果与结论通过研究美国的药品安全监管体制,提出我国药品安全监管体制的完善建议,如加强我国药品法律法规体系的建设,并完善药品安全统一监管模式的建设,提高药品安全监管技术层面上的建设等。
|
| 关 键 词： | 美国 药品安全 监管体制 |
The Revelation of American Drug Safety Regulatory Regime |
| |
| GUO Ying,YUAN Hong-mei.The Revelation of American Drug Safety Regulatory Regime[J].Chinese JOurnal of Pharmacovigilance,2013(10):607-608,613. |
| |
| Authors: | GUO Ying YUAN Hong-mei |
| |
| Institution: | (Shenyang Pharmaceutical University School of Business Administration, Liaoning Shenyang 110016, China) |
| |
| Abstract: | Objective To study American drug safety regulatory regime and put forward some suggestions to solve some problems in our drug safety supervision systerrL Methods Literature analysis was used in this paper. Results ＆ Conclusion By studying American drug safety regulatory regime, some suggestions were put forward, such as the system construction of China＇s drug laws and regulations, the construction of unified drug safety regulatory approach and the construction of drug safety supervision in the technical aspects. |
| |
| Keywords: | America drug safety regulatory regime |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
